rs751631278
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_025152.3(NUBPL):c.693+1G>A variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000291 in 1,613,132 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_025152.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 249240Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135218
GnomAD4 exome AF: 0.0000308 AC: 45AN: 1460954Hom.: 0 Cov.: 31 AF XY: 0.0000316 AC XY: 23AN XY: 726848
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152178Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74332
ClinVar
Submissions by phenotype
Mitochondrial complex 1 deficiency, nuclear type 21 Pathogenic:3
- -
- -
Variant summary: NUBPL c.693+1G>A is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing and loss of NUBPL function. Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes a canonical 5' splicing donor site. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 1.6e-05 in 249240 control chromosomes. c.693+1G>A has been reported in the literature in individuals affected with features of Mitochondrial Complex 1 Deficiency (examples:Kimonis_2020, Friederich_2020, Haskell_2018). These data indicate that the variant is likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 31917109, 32518176, 29417091). ClinVar contains an entry for this variant (Variation ID: 50216). Based on the evidence outlined above, the variant was classified as pathogenic. -
not provided Pathogenic:2
This sequence change affects a donor splice site in intron 8 of the NUBPL gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in NUBPL are known to be pathogenic (PMID: 23553477, 31917109). This variant is present in population databases (rs751631278, gnomAD 0.003%). Disruption of this splice site has been observed in individual(s) with mitochondrial complex I deficiency (PMID: 29417091, 31917109, 32518176). ClinVar contains an entry for this variant (Variation ID: 50216). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 31917109, 30094188, 34426522, 29417091, 32518176) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at